| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 27 |
| 1 | ASPIRIN | 25 |
| 2 | ASPIRIN 325 MG | 25 |
| 3 | ASPIRIN 81 MG | 25 |
| 4 | FUROSEMIDE | 22 |
| 5 | CLOPIDOGREL | 16 |
| 6 | ADALIMUMAB | 14 |
| 7 | PREDNISOLONE | 13 |
| 8 | PREDNISOLONE ORAL | 13 |
| 9 | PREDNISOLONE ORAL SOLUTION | 13 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 44 |
| 1 | Factor Xa Inhibitor [EPC] | 35 |
| 2 | Corticosteroid [EPC] | 27 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 25 |
| 4 | Loop Diuretic [EPC] | 24 |
| 5 | Proton Pump Inhibitor [EPC] | 15 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 13 |
| 7 | Aldosterone Antagonist [EPC] | 11 |
| 8 | Benzodiazepine [EPC] | 11 |
| 9 | Calcium Channel Blocker [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 1 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 3 | Antifibrinolytic Agent [EPC] | 3 | 0.0003 |
| 4 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 5 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 6 | Orexin Receptor Antagonist [EPC] | 4 | 0.0002 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 2 | 0.0002 |
| 8 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0001 |
| 9 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |